Key Insight: Discover how GLP1 drugs may dampen alcohol cravings via brain reward pathways
Jiang T, Zhu J, Jiang S, Chen Z, Xu P, Gong R, et al
The influence of GLP-1 receptor agonist drugsoriginally developed to treat type 2 diabeteson consumers, manufacturers, and the entire food industry is unprecedented in both its nature and scope
23, 24 Caspase-3, caspase-9, poly ADP ribose polymerase and anti-rabbit immunoglobulin G horseradish peroxidase antibodies were from Cell Signaling (Danvers, MA, USA)
This makes dietary and behavioural strategies especially meaningful for individuals with impaired GLP-1 signalling, such as those with insulin resistance, obesity or type 2 diabetes
The working principle is as follows: The growth hormone causes the liver to manufacture IGF-1, which then takes charge of many of GHs anabolic effectssuch as encouraging cell growth, protein synthesis, and tissue repair